CIK 0001526119
- Non-accelerated filer
- Smaller reporting company
Verastem, Inc.
Sign in to watch- Ticker
- VSTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 273269467
- Phone
- +1 781-292-4200
- Business address
- 117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $386,390
- in 4 filings, $386K under 10b5-1 plans
Net −$386,390. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-03 | Bloom Steven H. Chief Strategy Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-01-03 | Bloom Steven H. Chief Strategy Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2018-09-24 | Bloom Steven H. Chief Strategy Officer | Grant or award · Stock Option (Right to Buy) | +28,000 | 28,000 | ||
| 2018-06-08 | Bloom Steven H. Chief Strategy Officer | Purchase | +3,000 | $5.98 | $18K | 3,500 |
| 2018-04-06 | Bloom Steven H. Chief Strategy Officer | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2018-01-05 | Bloom Steven H. Chief Strategy Officer | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 |
Page 1 of 1 · 6 trades